Clinical trial
Intradiscal Gelified Ethanol Versus Intradiscal Steroid in Refractory Lumbar Discogenic Pain: a Randomized Single-blind Study
NCT03415828 is registered in ClinicalTrials.gov with Gelscom SAS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intradiscal Gelified Ethanol Versus Intradiscal Steroid in Refractory Lumbar Discogenic Pain: a Randomized Single-blind Study
- Lead sponsor
- Gelscom SAS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 29, 2018
- Completion date
- May 29, 2027
- Enrollment
- 230 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
lumbar discogenic pain (disorder)